Stephen Chelko | Toxicology and Pharmaceutical Science | Innovative Research Award

Published on by Invention Awards

Innovative Research Award

Stephen Chelko
Florida State University College of Medicine

Stephen Chelko
Affiliation Florida State University College of Medicine
Country United States
Scopus ID 54973874200
Documents 47
Citations 1,649
h-index 18
Subject Area Toxicology and Pharmaceutical Science
Event International Invention Awards
ORCID 0000-0003-1675-5945

Stephen Chelko is a researcher affiliated with the Florida State University College of Medicine whose documented scholarly profile is associated with toxicology and pharmaceutical science. Available bibliometric information records 47 documents, 1,649 citations, and an h-index of 18, providing a quantitative basis for assessing research visibility and scholarly influence. [1]

Abstract

Stephen Chelko is a researcher associated with Florida State University College of Medicine and the fields of toxicology and pharmaceutical science. His indexed scholarly record comprises 47 documents, 1,649 citations, and an h-index of 18, according to the supplied Scopus profile information. These indicators provide a measurable basis for describing his research visibility and citation impact within scholarly databases. His profile may be considered in the context of recognition for innovative research, particularly where scientific investigation, translational relevance, and contribution to biomedical knowledge are central criteria. The Innovative Research Award provides a framework for highlighting documented scholarly achievement and research significance.

Keywords

Stephen Chelko; Innovative Research Award; toxicology; pharmaceutical science; biomedical research; Florida State University College of Medicine; research impact; scholarly publications; citation analysis; translational science.

Introduction

Academic recognition commonly considers the quality, relevance, originality, and influence of a researcher’s scholarly work. In this context, Stephen Chelko’s documented profile combines research activity in toxicology and pharmaceutical science with measurable bibliometric indicators. The available Scopus record identifies 47 documents, 1,649 citations, and an h-index of 18. [1]

Research Profile

Chelko’s stated subject area is Toxicology and Pharmaceutical Science, positioning his scholarly profile within disciplines concerned with biological effects, therapeutic development, pharmaceutical research, and related biomedical questions. His affiliation with Florida State University College of Medicine further places this work within an academic medical environment. [4]

Research Contributions

The available information supports describing Chelko’s contribution through his documented publication record and citation footprint rather than assigning unsupported claims about individual discoveries. Forty-seven indexed documents indicate sustained scholarly output, while the recorded citation count suggests that his published research has been referenced by subsequent academic literature. [1]

Publications

The supplied researcher profile reports 47 documents indexed in Scopus. Because complete publication titles, journals, publication years, and article-level DOI information were not supplied, this page does not attribute individual papers or DOI records without verification. The Scopus author profile provides the appropriate source for reviewing the complete indexed publication record. [1]

Research Impact

Research impact can be assessed through several complementary dimensions, including scholarly citations, publication continuity, disciplinary relevance, and potential contribution to scientific practice. Chelko’s reported 1,649 citations and h-index of 18 provide quantitative indicators of scholarly visibility, although bibliometric measures should be interpreted alongside qualitative assessment of research originality and significance. [1]

Award Suitability

The documented research profile is relevant to an Innovative Research Award because it demonstrates sustained scholarly activity in a biomedical subject area and a measurable citation record. Final award suitability should nevertheless depend on the official nomination criteria, verified publications, originality of contributions, supporting evidence, and independent evaluation by the responsible award committee. [5]

Conclusion

Stephen Chelko’s supplied academic profile presents a researcher working in toxicology and pharmaceutical science, affiliated with Florida State University College of Medicine. The reported record of 47 documents, 1,649 citations, and an h-index of 18 provides a measurable foundation for academic recognition. These indicators should be considered together with verified research quality and innovation.

References

  1. Elsevier. (n.d.). Scopus author details: Stephen Chelko, Author ID 54973874200. Scopus.
    https://www.scopus.com/pages/authors/54973874200
  2. ORCID. (n.d.). Stephen Chelko, ORCID iD 0000-0003-1675-5945. ORCID.
    https://orcid.org/0000-0003-1675-5945
  3. Google Scholar. (n.d.). Stephen Chelko — Google Scholar profile.
    https://scholar.google.com/citations?hl=en&user=5Hq6SM0AAAAJ
  4. Journal article. (2019.). Therapeutic Modulation of the Immune Response in Arrhythmogenic Cardiomyopathy.
    https://doi.org/10.1161/CIRCULATIONAHA.119.040676
  5. International Invention Awards. (2026.). Official Award Information.
    https://inventionawards.org/

Dr. Dina Aboushady | Pharmaceutical Analysis | Best Researcher Award

Published on by Invention Awards

Dr. Dina Aboushady | Pharmaceutical Analysis | Best Researcher Award

German University in Cairo, Egypt.

Dr. Dina Aboushady is a distinguished Postdoctoral Lecturer Assistant in the Faculty of Pharmacy and Biotechnology at the German University in Cairo (GUC), specializing in pharmaceutical chemistry. With a deep passion for drug design and bioanalysis, her research bridges innovative solutions in chiral recognition and pharmaceutical quality. She has significantly contributed to the development of quinazoline derivatives and enantiomeric resolution methods. Her career is marked by numerous awards, including prestigious scholarships and research fellowships. Dr. Aboushady also brings valuable teaching experience to her role at GUC and GIU (German International University).

Profile

Orcid

Education 🎓

Dr. Aboushady obtained her Bachelor's degree in Pharmacy and Biotechnology from the German University in Cairo (GUC) in 2014, graduating with highest honors. She continued her studies and earned a Master's of Science in Pharmaceutical Chemistry in 2016 with excellent grades. Her Doctor of Philosophy (Ph.D.) in Pharmaceutical Chemistry was awarded in 2021, focusing on Quality by Design for Bioanalysis and chiral recognition. Her commitment to research excellence was further recognized with scholarships such as the DAAD/BMBF/GUC funded fellowship and the full Ph.D. fellowship from GUC.

Experience 💼

Dr. Aboushady currently serves as a Postdoctoral Lecturer Assistant at GUC and a Part-time Lecturer at the German International University (GIU), teaching courses like Physical Chemistry, Analytical Chemistry, and Instrumental Analysis. Her teaching extends across several campuses in Cairo and Berlin. Additionally, she has contributed to various workshops such as Grant Writing and LC-MS Essential Operator workshops, emphasizing her active role in academic development and mentoring.

Research Interests 🔬

Pharmaceutical Chemistry Expertise 🔬
Dr. Dina Aboushady specializes in pharmaceutical chemistry, focusing on the design and synthesis of novel drug molecules. Her work includes developing innovative bioanalytical methods that advance the understanding and application of pharmaceutical compounds.

Enantio-Separation and Supercritical Fluid Chromatography (SFC) 🔍
A major part of Dr. Aboushady's research lies in enantio-separation, a process critical to the bioanalysis and quality control of pharmaceutical products. She utilizes supercritical fluid chromatography (SFC), a powerful technique to separate chiral compounds, enabling more precise drug quality assessment and development.

Chiral Recognition in Drug Design 💊
Dr. Aboushady's contributions to chiral recognition are pivotal in optimizing the effectiveness of pharmaceutical products. By understanding and improving how drugs interact with their chiral forms, she plays a crucial role in ensuring that drugs are both safe and effective.

Pharmaceutical Analysis and Drug Quality Control 🔬
Her research in pharmaceutical analysis focuses on improving drug quality control through advanced separation techniques. Dr. Aboushady’s work ensures that pharmaceutical products meet the required standards for efficacy and safety, contributing significantly to drug development and bioanalysis.

Awards 🏆

DAAD/BMBF/GUC Scholarship (2019-2020) for research stay in Germany.

Full Ph.D. Fellowship (2016-2021) at GUC.

Academic Excellence Scholarship (2009-2014) for Bachelor studies at GUC.

DAAD Scholarship for Drug Design Course (Summer 2013) in Germany.

Selected Publications 📚

Aboushady, D., Parr, M. K., Hanafi, R. S., Quality-by-Design Is a Tool for Quality Assurance in the Assessment of Enantioseparation of a Model Active Pharmaceutical Ingredient. Pharmaceuticals, 2020, 13(11), 364.

Aboushady, D., Rasheed, S. S., Herrmann, J., Novel 2,4-disubstituted quinazoline analogs as antibacterial agents with improved cytotoxicity profile. Bioorg Chem., 2021, 117, 105422.

Aboushady, D., Hanafi, R. S., Parr, M. K., Quality by design approach for enantioseparation of terbutaline and its sulfate conjugate metabolite for bioanalytical application using supercritical fluid chromatography. J Chromatogr A., 2022, 1676, 463285.

Aboushady, D., Samir, L., Masoud, A., Chemometric Approaches for Sustainable Pharmaceutical Analysis Using Liquid Chromatography. Chemistry, 2025, 7(1), 11.